• Consumer paint stripper use - prohibited
• Professional use - permitted with training and controls
• Industrial use - permitted, OEL applies (EH40 WEL)
• UK WEL (EH40): 100 ppm TWA / 300 ppm STEL
• COSHH Regulations 2002 apply to all workplace use

• Non-UK manufacturers importing >1 tonne/year must register under UK REACH separately from EU REACH
• EU REACH registration does NOT cover UK supply post-Brexit
• UK Only Representative (UK OR) system mirrors EU OR model
• UK SDS format follows UK-specific GHS labelling requirements
• Deadline for grandfathered registration data: verify with HSE

• UK may diverge from EU REACH in future reviews
• IARC Group 1 reclassification may prompt HSE to review DCM WEL downward
• UK Retained EU Law review may affect substance of Annex XVII equivalents
• Monitor HSE's COSHH Essential Chemicals updates for DCM

All uses of DCM are currently permitted in India. The primary regulatory instruments are the Factories Act 1948 (occupational health), the Manufacture, Storage and Import of Hazardous Chemicals (MSIHC) Rules 1989, and the Environment Protection Act. India has no DCM-specific use restriction beyond general hazardous chemical management. The OEL is 100 ppm TWA (aligned with older ACGIH TLV). India is a growing market for DCM imports from China for pharma, agrochemical, and textile industries.

Singapore, Thailand, Vietnam, Indonesia, Malaysia, and the Philippines all permit DCM for industrial use without the specific restrictions seen in the US and EU. Singapore regulates DCM under the Workplace Safety and Health Act and Environment Protection regulations. Thailand lists DCM in its Hazardous Substance List (Type 3) requiring licence for import and storage. Vietnam and Indonesia have general hazardous chemical frameworks that apply. Verify country-specific import licence requirements before shipping - several SE Asian markets require import permits for DCM as a hazardous substance.

The Gulf Cooperation Council (GCC) countries - Saudi Arabia, UAE, Qatar, Bahrain, Kuwait, Oman - permit DCM for industrial use. No consumer restrictions equivalent to US/EU are in place as of 2025. Turkey has aligned its chemical regulations with EU standards under its accession framework - Turkey's KKDIK regulation (Turkish REACH) mirrors EU REACH, meaning the Annex XVII restriction on DCM paint strippers applies in Turkey. Verify current KKDIK status for specific uses before supply.

IARC Group 1 strengthens the EPA's basis for tighter TSCA restrictions on remaining permitted uses. Expect the ongoing TSCA risk evaluation to use the Group 1 classification as a factor in unreasonable risk determinations for industrial uses. OSHA may also review its DCM PEL (25 ppm) in light of the reclassification - potential downward revision is possible.

ECHA's Committee for Risk Assessment (RAC) will likely review DCM's harmonised classification under CLP Regulation in light of IARC Group 1. Current EU CLP classification (Carc. 1B) may be upgraded to Carc. 1A. An OEL review under the Chemical Agents Directive is also possible. SVHC authorisation pathway may be pursued by ECHA as a next step.

The ICH Expert Working Group may review DCM's Class 2 classification and PDE (6.0 mg/day, 600 ppm limit) following the IARC upgrade. A formal ICH Q3C revision could lower the permitted limit, affecting pharmaceutical manufacturers who rely on DCM. Current limits remain operative until any revision is formally adopted.

Countries that align with IARC classifications for regulatory purposes - including Australia (Safe Work), Canada (WHMIS), and Japan - may update their DCM OELs or hazard classifications in response to the Group 1 upgrade. Buyers in these markets should monitor relevant authority updates through 2025–2026.

EPA is expected to complete its comprehensive TSCA risk evaluation for all DCM uses in 2025–2026. A finding of unreasonable risk for industrial uses (degreasing, extraction, etc.) could trigger new rulemaking. The IARC Group 1 classification strengthens the EPA's hand. Timeline: expect proposed rules 2026–2027 if unreasonable risk is found.

ECHA's RAC is expected to evaluate upgrading DCM's CLP classification to Carc. 1A in light of IARC Group 1. A CLP Carc. 1A classification would trigger automatic review of the OEL under Directive 2004/37/EC (CMD). Downward OEL revision - potentially to 25–50 ppm TWA - is plausible by 2026–2027, which would significantly increase compliance costs for EU industrial users.

ICH Expert Working Groups periodically revise Q3C. The IARC Group 1 reclassification creates pressure to review the 600 ppm limit and 6.0 mg/day PDE for DCM. If the PDE is reduced - for example to align with a lower NOEL from more recent animal data - pharmaceutical manufacturers would face costly process changes. Watch ICH Expert Working Group announcements.

Australia, South Korea, Japan, and Taiwan are likely to progressively tighten DCM OELs in response to the IARC upgrade. India and Southeast Asian countries may face pressure from international trade partners to implement use restrictions as a condition of market access. China may face VOC emission restrictions that reduce domestic DCM use - though export is unlikely to be affected in the short term.

Q1: Is DCM banned globally?

No - there is no global ban on DCM. Restrictions are jurisdiction-specific and use-specific. Consumer paint stripping with DCM is banned in the US, EU, and UK. Industrial and professional use remains permitted in those markets with controls. In China, India, most of Southeast Asia, the Middle East, and Latin America, all uses of DCM are currently permitted. The global regulatory direction is toward tighter controls, but implementation timelines vary significantly by country.

Q2: Can I import DCM from China into the US for industrial use?

Yes, for permitted industrial uses - but with important considerations. First, the Section 301 tariff currently imposes a 25% additional duty on DCM imported from China into the US (HS 2903.12), which significantly affects pricing competitiveness versus domestic or other-origin material. Second, for paint-stripping uses, you must ensure your customers have WCPP programmes in place and that you are complying with the TSCA downstream notification requirement. For non-paint-stripping uses (pharmaceutical, food-grade, general industrial), standard import procedures apply without the additional WCPP compliance burden.

Q3: What does the IARC Group 1 reclassification mean for buyers right now?

In the immediate term (2025), the IARC Group 1 classification does not directly change any legal limit or regulatory requirement - it is a scientific hazard assessment, not a regulatory decision. However, it signals that regulatory bodies (EPA, ECHA, HSE, ICH) are likely to tighten limits in coming years. Practically, buyers should: (1) begin evaluating whether alternative solvents are technically feasible for their key uses; (2) review occupational exposure monitoring to ensure exposure is well below current OELs; (3) flag the classification to their regulatory affairs teams for proactive review; (4) monitor regulatory dockets in their key markets for proposed rule changes.

Q4: Does EU REACH registration cover supply into the UK?

No - since Brexit, EU REACH and UK REACH are completely separate legal regimes. A REACH registration number from an EU-based Only Representative does not cover supply into the UK. Chinese suppliers or their UK-designated Only Representatives must separately register DCM under UK REACH with the HSE. Failure to have a UK REACH registration means the product cannot legally be placed on the UK market above the applicable tonnage threshold. If you are supplying both EU and UK markets, you need two separate registration processes.

Q5: Can I still buy DCM for pharmaceutical manufacturing in the EU?

Yes - the EU REACH Annex XVII restriction on DCM applies specifically to paint stripping use. Pharmaceutical manufacturing, chemical extraction, analytical laboratory use, and food-grade decaffeination remain fully permitted in the EU, subject to occupational exposure controls (OEL: 100 ppm TWA) and REACH compliance obligations. ICH Q3C Class 2 limits (600 ppm residual in product) continue to apply for pharmaceutical product quality purposes, independently of the REACH regulatory framework.

Q6: How should I decide which DCM uses are safe to supply given the evolving regulatory landscape?

A practical decision framework: (1) Identify destination market - US/EU/UK carry the highest regulatory risk for paint-stripping uses; (2) Confirm end-use in writing - request a written end-use declaration from your buyer; (3) Check prohibited uses - consumer paint stripping is banned in US/EU/UK; certain uses may be prohibited in specific markets; (4) Verify OEL compliance - even where use is permitted, ensure your buyer has workplace controls to meet the applicable OEL; (5) Document and retain records - keep end-use declarations and shipping records; (6) Monitor regulatory changes - subscribe to EPA, ECHA, and HSE update services for DCM-related regulatory actions.